Celgene Corp (CELG)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | CELG | GSK | REGN | ||
| Company | Celgene Corp | Gsk Plc ADR | Regeneron Pharmaceuticals | ||
| Price Information | |||||
| Exchange | NASDAQ | NYSE | NASDAQ | ||
| Open | 108.01 | 50.26 | 672.55 | ||
| High | 108.59 | 51.31 | 678.67 | ||
| Low | 107.27 | 50.16 | 666.87 | ||
| Latest | 108.24 | 50.78 | 675.19 | ||
| Change | +0.11 | +0.74 | +3.04 | ||
| % Change | +0.10% | +1.48% | +0.45% | ||
| Volume | 191,230,496 | 3,901,399 | 529,256 | ||
| 20-Day Average Volume | 16,188,930 | 3,878,435 | 781,698 | ||
| Previous Close | 108.13 | 50.04 | 672.15 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | No | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 108.17 | 52.11 | 651.84 | ||
| 20-Day Raw Stochastic | 63.25% | 18.09% | 80.85% | ||
| 20-Day Relative Strength | 64.69 | 45.88 | 56.46 | ||
| Weighted Alpha | +46.30 | +23.91 | +12.48 | ||
| Today's Opinion | 100% Buy | 32% Sell | 40% Sell | ||
| Previous Opinion | 100% Buy | 32% Sell | 40% Sell | ||
| Last Month's Opinion | 100% Buy | 8% Sell | 88% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -1.97% since 11/13/19 | -0.92% since 07/14/26 | +2.91% since 07/14/26 | ||
| Low | 107.27 on 11/20/19 | 50.01 on 07/20/26 | 648.66 on 07/15/26 | ||
| High | 110.53 on 11/14/19 | 52.85 on 07/16/26 | 691.13 on 07/17/26 | ||
| 1-Month | |||||
| %Chg | +5.14% since 10/18/19 | +0.22% since 06/18/26 | +10.70% since 06/18/26 | ||
| Low | 102.40 on 10/21/19 | 50.01 on 07/20/26 | 594.90 on 06/22/26 | ||
| High | 110.70 on 11/13/19 | 54.29 on 07/07/26 | 691.13 on 07/17/26 | ||
| 3-Month | |||||
| %Chg | +13.63% since 08/20/19 | -9.52% since 04/21/26 | -9.66% since 04/21/26 | ||
| Low | 93.41 on 08/23/19 | 48.57 on 06/02/26 | 591.52 on 06/02/26 | ||
| High | 110.70 on 11/13/19 | 56.34 on 04/22/26 | 767.21 on 04/23/26 | ||
| 6-Month | |||||
| %Chg | +14.14% since 05/20/19 | +5.64% since 01/21/26 | -9.89% since 01/21/26 | ||
| Low | 89.08 on 07/23/19 | 48.08 on 01/22/26 | 591.52 on 06/02/26 | ||
| High | 110.70 on 11/13/19 | 61.69 on 02/18/26 | 815.00 on 02/17/26 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 77,035,920 | 101,215,808 | 71,059,696 | ||
| Shares Outstanding, K | 711,714 | 2,022,698 | 105,720 | ||
| Annual Sales | 15,281,000,000 | 43,077,970,000 | 14,342,900,000 | ||
| Annual Net Income | 4,046,000,000 | 7,537,690,000 | 4,504,900,000 | ||
| Last Quarter Sales | 4,520,000,000 | 10,280,080,000 | 3,605,400,000 | ||
| Last Quarter Net Income | 1,691,000,000 | 2,340,610,000 | 727,200,000 | ||
| 60-Month Beta | 1.41 | 0.35 | 0.24 | ||
| Per-Share Information | |||||
| Most Recent Earnings | 2.99 on 10/31/19 | 1.24 on 04/29/26 | 9.47 on 04/29/26 | ||
| Earnings Date | 01/30/20 | 07/28/26 | 07/30/26 | ||
| Most Recent Dividend | N/A | 0.447 on 05/15/26 | 0.940 on 05/20/26 | ||
| Next Ex-Dividends Date | N/A | 05/15/26 | 05/20/26 | ||
| Ratios | |||||
| Price/Earnings ttm | 10.99 | 11.18 | 18.22 | ||